Back

Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants versus warfarin in non-valvular atrial fibrillation patients: the dose subgroup analysis of the ARISTOPHANES study

26 August 2018 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Atrial fibrillation - Stroke prevention - General Oral Anticoagulation ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Xiaoyan Li

Princeton (United States of America)

8 More presentations in this session

Presentation thumbnail
Associate Professor E. Grove (Aarhus, DK)
Abstract Slides
Presentation thumbnail
Ms K. Pieper (London, GB)
Abstract Slides
Presentation thumbnail
Professor G. Lip (Liverpool, GB)
Abstract Slides
Presentation thumbnail
Professor U. Zeymer (Ludwigshafen, DE)
Abstract
Presentation thumbnail
Doctor A. Bisson (Tours, FR)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 3 - Atrial fibrillation - Stroke prevention - General

The Event

Event poster

ESC Congress 2018

26 August 2018 14:00 CET
You may be interested in
thumbnail
Congress Session
Stroke prevention in clinical and subclinical atrial fibrillation
thumbnail
Congress Session
Oral anticoagulation in subclinical atrial fibrillation
thumbnail
Congress Session
EHRA Myths - Device-detected atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources